NLVP
EWTX icon

New Leaf Venture Partners’s Edgewise Therapeutics EWTX Stock Holding History

New Leaf Venture Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$16.7M Hold
1,030,161
– – 38.82% 1
2025
Q2 		$13.5M Hold
1,030,161
– – 25.51% 2
2025
Q1 		$22.7M Hold
1,030,161
– – 50.47% 1
2024
Q4 		$27.5M Sell
1,030,161
-523,500
-34% -$16.7M 36.77% 2
2024
Q3 		$41.5M Hold
1,553,661
– – 42.62% 1
2024
Q2 		$28M Hold
1,553,661
– – 34.03% 2
2024
Q1 		$28.3M Hold
1,553,661
– – 24.8% 2
2023
Q4 		$17M Hold
1,553,661
– – 13.69% 3
2023
Q3 		$8.9M Hold
1,553,661
– – 11.43% 4
2023
Q2 		$12M Hold
1,553,661
– – 10.34% 5
2023
Q1 		$10.4M Hold
1,553,661
– – 8.56% 5
2022
Q4 		$13.9M Hold
1,553,661
– – 10.06% 4
2022
Q3 		$15.3M Hold
1,553,661
– – 9.07% 4
2022
Q2 		$12.4M Hold
1,553,661
– – 8.01% 4
2022
Q1 		$15.1M Hold
1,553,661
– – 7.43% 4
2021
Q4 		$23.7M Hold
1,553,661
– – 8.6% 3
2021
Q3 		$25.8M Hold
1,553,661
– – 7.44% 4
2021
Q2 		$43.8M Hold
1,553,661
– – 11.24% 3
2021
Q1 		$50.5M Buy
+1,553,661
New +$50.4M 11.75% 4

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

New Leaf Venture Partners's EWTX Position: Q3 2025 in Review

New Leaf Venture Partners held its Edgewise Therapeutics (EWTX) position steady in Q3 2025 at 1,030,161 shares worth $16.7M. The position accounts for 38.82% of the portfolio, ranked #1.

New Leaf Venture Partners first reported a position in EWTX in Q1 2021 and has held it in 19 quarters since. The position peaked at $50.5M in Q1 2021. 173 funds tracked by Wall St. Rank hold EWTX as of Q3 2025.

  • New Leaf Venture Partners held 1,030,161 shares of Edgewise Therapeutics worth $16.7M as of Q3 2025.
  • New Leaf Venture Partners left its Edgewise Therapeutics share count unchanged in Q3 2025.
  • Edgewise Therapeutics made up 38.82% of New Leaf Venture Partners's portfolio in Q3 2025, its #1 holding.
  • New Leaf Venture Partners first reported a position in Edgewise Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • New Leaf Venture Partners's Edgewise Therapeutics position peaked at $50.5M in Q1 2021.
  • 173 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2025.

Based on New Leaf Venture Partners's 13F filing for Q3 2025, filed 14 Nov 2025.